A study for evaluation of different diagnostic approaches in acute leukemia in Egypt

References

• Bear MR, Stewart CC, Lawrence D, et al. Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22). Blood 199790:1643-1648.
   PubMed Web of Science ®Google Scholar
• Casasnovas RO, Slimane FK, Garand R, Faure GC, Campos L, Deneys V, Bernier M, et al. Immunological classification of acute myeloblastic leukemias: Relevance to patient outcome. Leukemia 2003;17 (3):515–527 .
   PubMed Web of Science ®Google Scholar
• Elia L, Mancini M, Moleti L, Meloni G, Buffolino S, Krampera M, De Rossi G, Foa R, Cimino G. A multiplex reverse transcriptase-polymerase chain reaction strategy for the diagnostic molecular screening of chimeric genes: A clinical evaluation on 170 patients with acute lymphoblastic leukemia. Haematologica 2003;88 (3) :275— 279.
   PubMed Web of Science ®Google Scholar
• Frank R, Zhang J, Uchida H, Meyers S, Hiebert SW, Nimer SD. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene 1995; 11(12):2667–2674.
   PubMed Web of Science ®Google Scholar
• Giles FL Novel agents for the therapy of acute leukemia. Curr Opin Oncol 2002;14(1):3–9.
   PubMed Web of Science ®Google Scholar
• Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of hematologic malignancies report of the clinical advisory committee meeting. Airlie House Virginia, November 1997. Mol Pathol 2000;13(2):193–207.
   Google Scholar
• Hiem S, Mitelman F. Acute lymphoblastic leukemia. In: Heim S, Mitelman F, editors. Cancer cytogenetics. 2nd ed. New York: Wiley; 1995. p 180.
   Google Scholar
• Hoelzer D, Gokbuget N. New approaches in acute lympho-blastic leukemia in adults: Where do we go? Semin Oncol 2000;27:540–559.
   PubMed Web of Science ®Google Scholar
• ISCN. In: Mitlman F, editor. An international system for human cytogenetics nomenclature. Basel, Switzerland: Skar-ger; 1995. p 16.
   Google Scholar
• jam S, Potter M, Rabkin CS. Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals. Genes Chromosomes Cancer 2003;36(3):211–223.
   PubMed Web of Science ®Google Scholar
• Kaleem Z, Crawford E, Pathan MH, Jasper L, Covinsky MA, Johnson LR, White G. Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data. Arch Pathol Lab Med 2003;127 (1):42–48.
   PubMed Web of Science ®Google Scholar
• Kelly L, Clark J, Gilliland DG. Comprehensive genotypic analysis of leukemia: Clinical and therapeutic implications. Curr Opin Oncol 2002;14(1):10–18.
   PubMed Web of Science ®Google Scholar
• Khalidi H, Brynes RK, Medeiros U, Chang KU, Slovak ML, Snyder DS, Arber DA. The immunophenotype of blast transformation of chronic myelogenous leukemia: A high frequency of mixed lineage phenotype in "lymphoid" blasts and a comparison of morphologic, immunophenotypic, and molecular findings. Mod Pathol 1998;11: 1211–1221.
   PubMed Web of Science ®Google Scholar
• Kita K, Miwa H, Nakase K. Phenotypical characteristic of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: Frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood 1993;81: 3083–3090.
   PubMedGoogle Scholar
• Liu P, Tarle SA, Hajra A, Claxton DF. Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science 1993;261: 1041–1044.
   PubMed Web of Science ®Google Scholar
• Löwenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med 1999;341:1051–1062.
   PubMed Web of Science ®Google Scholar
• Löwenberg B. Prognostic factors in acute myeloid leukemia. Balliere’s Chin Hematol 2001;14:65–75.
   PubMed Web of Science ®Google Scholar
• Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, Davie JR, Huynh KD, Bardwell VJ, Lavinsky RM, Rosenfeld MG, Glass C, Seto E, Hiebert SW. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol Cell Biol 1998;18(12):7176–7184.
   PubMed Web of Science ®Google Scholar
• Mahmoud LA, ElKabsh M, Salem M, Aref S, Aladle D. Leukemias and myelodysplastic syndromes. In: Mahmoud LA, ElKabsh M, Salem M, Aref S, Aladle D, editors. Questions and answers in hematology. Part 1: White cell disorders. 1st ed. Dar El-Wafaa; 2002.
   Google Scholar
• Martinez-Climent JA, Lane NJ, Rubin CM. Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia. Leukemia 1995;9:95–101.
   PubMed Web of Science ®Google Scholar
• Mecucci C, Rosati R, Starza RL. Genetic profile of acute myeloid leukemia. Rev Chin Exp Hematol 2002;6(1):3–25.
   PubMedGoogle Scholar
• Mrozek K, Hienonen K, Bloomfield CD. Clinical importance of cytogenetics in acute myeloid leukemia. Bailliere’s Clin Hematol 2001;14:19–47.
   PubMed Web of Science ®Google Scholar
• Nguyen S, Leblane T, Fenaux P, Witz F. A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): A survey of 161 cases from the french AML intergroup. Blood 2002;99:3517–3523.
   PubMed Web of Science ®Google Scholar
• Nordgren A, Heyman M, Sahlen S, Schoumans J. Spectral karyotyping and interphase FISH reveal abnormalities not detected by conventional G-banding. Eur J Hematol 2002;68:31–41.
   PubMed Web of Science ®Google Scholar
• Nucifora G, Dickstein JI, Torbenson V, Roulston D, Rowley JD, Nucifora G, Rowley JD. AML1 and the 8; 21 and 3; 21 translocations in acute and chronic myeloid leukemia. Blood 1995;86: 1.
   PubMed Web of Science ®Google Scholar
• Reilly JT, Bain BJ, England JM, Kyde K, et al. The role of cytology, cytochemistry, immunophenotyping and cytogenetic analysis in the diagnosis of hematological neoplasms. Chin Lab Haem 1996;18:213–236.
   Google Scholar
• Solary E, Casasnovas RO, Campos L, et al. Surface markers in adult acute myeloblastic leukemia: Correlation of CD19+, CD34+ and CD14+/DR-phenotypes with shorter survival. Groupe d’Etude Immunologique des Leucemies (GEIL). Leukemia 1992;6:393.
   PubMed Web of Science ®Google Scholar
• Stasi R, Taylor CG, Venditt A, Del-Poeta G, Cox MC, Bruno A. Contribution of immunophenotyping and genotypic analysis to the diagnosis of acute leukemia. Ann Hematol 1993;71(1):13–27.
   Web of Science ®Google Scholar
• Surzycki S. PCR analysis. Basic techniques in molecular biology. Berlin, Germany: Springer-Verlag; 2000. p 405–421.
   Google Scholar
• Swansbury J. Acute lymphoblastic leukemia: Background. Methods Mol Biol 2003;220:59–71.
   PubMedGoogle Scholar
• Thomas X, Vila L, Campos L, Sabido O, Archimbaud E. Expression of N-CAM (CD56) on acute leukemia cells: Relationship with disease characteristics and outcome. Leuk Lymphoma 1995;19: 295–300.
   PubMed Web of Science ®Google Scholar
• Urbano-Ispizua A, Cervantes F, Matutes E, Villamor N, Rzman C. Immunophenotypic characteristics of blast crises of chronic myeloid leukemia: Correlations with clinicobiological features and survival. Leukemia 1992;7:1349.
   Web of Science ®Google Scholar
• Vardiman JW. Chronic myelogenous leukemia and the myeloproliferative disorders. In: Knowles D, editor. Neoplas-tic hematopathology. 1st ed. Blatimore, MD, USA: Williams and Wilkins; 1992. p 1405–1438.
   Google Scholar
• Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002;100(7):2292–2302.
   PubMed Web of Science ®Google Scholar
• Varella-Garcia M, Hogan J, Odom F, Murata-Collins L, Chen L, Rickind K, Paskulin G, Andreef M, Brizard A, McGavran L, Gemmill M, Berger R, Drabkin A. Minimal residual disease in remission t(8;21) AML and in vivo differentiation detected by FISH and CD34+ cell sorting. Leukemia 2001; 15:1408–1414.
   PubMed Web of Science ®Google Scholar
• Verna RS, Babu A. Human chromosomes: Principles and techniques. New York: McGraw-Hill; 1995. p 28.
   Google Scholar